MiMedx Group, Inc. (MDXG)
7.17
+0.19
(+2.72%)
USD |
NASDAQ |
Dec 11, 12:03
MiMedx Group EPS Diluted (Quarterly): 0.1119 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| ADMA Biologics, Inc. | 0.1489 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| Praxis Precision Medicines, Inc. | -3.364 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 16.75M |
| Revenue (Quarterly) | 113.72M |
| Total Expenses (Quarterly) | 96.98M |
| Enterprise Value | 909.88M |
| Gross Profit Margin (Quarterly) | 83.44% |
| Profit Margin (Quarterly) | 14.73% |
| Earnings Yield | 3.81% |
| Operating Earnings Yield | 5.03% |
| Normalized Earnings Yield | 3.814 |